Aktie A1JX05 PACGEN LIFE SCIENCE CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Pacgen Life Science Corporation

Aktien

A1JX05

CA69374M1041

PBS

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Pacgen Life Science : Successfully Completes its Plan of Arrangement
Pacgen Life Science : IIROC Trading Halt - PBS
General Biologicals Corporation completed the acquisition of additional 77% stake in Pacgen Life Science Corporation.
Pacgen Life Science : Announces Shareholder Approval of Acquisition by General Biologicals Corporation
Pacgen Life Science Corporation Reports Earnings Results for the First Quarter Ended June 30, 2020
Pacgen Life Science Corporation Reports Earnings Results for the Full Year Ended March 31, 2020
Pacgen Life Science : Announces Proposed Acquisition by General Biologicals Corporation
General Biologicals Corporation entered into a letter of intent to acquire additional 77% stake in Pacgen Life Science Corporation for CAD 1.4 million.
Pacgen Life Science Corporation Reports Earnings Results for the Third Quarter Ended December 31, 2019
Pacgen Life Science Corporation Reports Earnings Results for the Second Quarter Ended September 30, 2019
Pacgen Life Science Corporation Reports Earnings Results for the First Quarter Ended June 30, 2019
Pacgen Life Science Corporation Reports Earnings Results for the Full Year Ended March 31, 2019
Pacgen Life Science Corporation Reports Earnings Results for the Third Quarter Ended December 31, 2018
Pacgen Life Science Corporation Announces Management Changes
Pacgen Life Science Corporation Appoints Rakesh Arya as Board of Directors
Pacgen Life Science Corporation announced that it has received CAD 0.74 million in funding
Pacgen Life Science Corporation Gains Exclusive Global Commercial Rights to DermaMed, DermaSoleil and Deserving Health
Pacgen Life Science Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2015
Pacgen Life Science Corporation announced that it has received CAD 0.32 million in funding from Southern Gold Resources Ltd and other investors.
Pacgen Life Sciences Corporation Announces Christina Yip to Board of Directors
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1JX05 Aktie
  4. Nachrichten Pacgen Life Science Corporation
  5. Andere Sprachen